A single-step high-throughput bioassay for quantifying Fc-containing recombinant proteins based on non-classical calculation of fluorescence polarization
文献类型:期刊论文
作者 | Zheng, Yujuan2,4; Chen, Ganjun3; Liu, Guojian1; Rana, Gul E.2,4; Wang, Chunhe2,3,4![]() |
刊名 | ANALYTICAL METHODS
![]() |
出版日期 | 2024-06-20 |
卷号 | 16期号:24页码:3917-3926 |
ISSN号 | 1759-9660 |
DOI | 10.1039/d4ay00372a |
通讯作者 | Wang, Chunhe() |
英文摘要 | The titer of recombinant proteins is one of the key parameters in biopharmaceutical manufacturing processes. The fluorescence polarization (FP)-based assay, a homogeneous, high-throughput and real-time analytical method, had emerged as a powerful tool for biochemical analysis and environmental monitoring. In this study, an FP-based bioassay was utilized to quantify antibody fragment crystallizable (Fc)-containing proteins, such as recombinant monoclonal antibodies (mAbs) and mAb derivatives, in the cell culture supernatant, and the impacts of tracer molecular weight and FITC-coupling conditions on fluorescence polarization were methodically examined. Distinct from the fluorescence polarization potency calculated by classical formula, we for the first time proposed a new concept and calculation of fluorescence polarization intensity, based on which an analytical method with broader detection range and analysis window was established for quantifying Fc-containing proteins. This provided new ideas for the practical application of fluorescence polarization theory. The established method could detect 96 samples within 30 minutes, with dynamic titer range of 2.5-400 mg L-1, and a linear fitting R2 between the measured and actual concentration reaching 0.99. The method had great application prospects in determining the titer of recombinant proteins with Fc fragments, especially when applied to large-scale screening of high-yield and stable expression CHO cell lines commonly used in biopharmaceutical industry. A single-step and high-throughput bioassay based on non-classical calculation of fluorescence polarization for quantifying Fc-containing recombinant proteins in the cell culture supernatant. |
WOS关键词 | ANTIBODY ; FUSION ; PROBES |
资助项目 | Special Project for Research and Development in Key Areas of Guangdong Province[2022B1111070007] ; Key-Area Research and Development Program of Guangdong Province[32370958] ; Key-Area Research and Development Program of Guangdong Province[81872785] ; National Natural Science Foundation of China[LX211005] ; CAS Bohai Rim Advanced Research Institute for Drug Discovery Project[210205143867019] ; CAS Bohai Rim Advanced Research Institute for Drug Discovery Project[191022172638719] ; Major Scientific and Technological Special Project of Zhongshan City |
WOS研究方向 | Chemistry ; Food Science & Technology ; Spectroscopy |
语种 | 英语 |
WOS记录号 | WOS:001237962300001 |
出版者 | ROYAL SOC CHEMISTRY |
源URL | [http://119.78.100.183/handle/2S10ELR8/311576] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Wang, Chunhe |
作者单位 | 1.Shanghai Mabstone Biotechnol Co Ltd, Shanghai 201203, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 3.Dartsbio Pharmaceut Co Ltd, Zhongshan 528400, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, Biotherapeut Discovery Res Ctr, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Zheng, Yujuan,Chen, Ganjun,Liu, Guojian,et al. A single-step high-throughput bioassay for quantifying Fc-containing recombinant proteins based on non-classical calculation of fluorescence polarization[J]. ANALYTICAL METHODS,2024,16(24):3917-3926. |
APA | Zheng, Yujuan,Chen, Ganjun,Liu, Guojian,Rana, Gul E.,&Wang, Chunhe.(2024).A single-step high-throughput bioassay for quantifying Fc-containing recombinant proteins based on non-classical calculation of fluorescence polarization.ANALYTICAL METHODS,16(24),3917-3926. |
MLA | Zheng, Yujuan,et al."A single-step high-throughput bioassay for quantifying Fc-containing recombinant proteins based on non-classical calculation of fluorescence polarization".ANALYTICAL METHODS 16.24(2024):3917-3926. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。